Fundz

Ten63 Therapeutics, Inc. reported raising $2.15 Million in an initial SEC Form D filing, from an offering of $2.15 Million

PRIVATEJan 27, 2021

Amount Raised

$2.15 Million

$2.15 Million sold, per SEC Form D (first sale Jan 27, 2021)

Round Type

Seed

DurhamOtherBiotechnology

Quick answer

Ten63 Therapeutics raised $2.15 Million in a Seed round, dated January 27, 2021. Ten63 Therapeutics is based in Durham, North Carolina, United States.

How much did Ten63 Therapeutics raise?
Ten63 Therapeutics raised $2.15 Million in a Seed round on January 27, 2021.
What does Ten63 Therapeutics do?
Ten63 Therapeutics is focused on improving human health by developing better, more durable therapeutics against cancer and some of the world’s most lethal diseases.
Where is Ten63 Therapeutics based and how big is it?
Ten63 Therapeutics is based in Durham, North Carolina, United States.
Who are the decision-makers at Ten63 Therapeutics?
Fundz holds 1 contact at Ten63 Therapeutics, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Ten63 Therapeutics that raised within 45 days of this round, from Fundz verified event records.

Who to call at Ten63 Therapeutics, and when

A new round usually means Ten63 Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ten63 Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ten63 Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ten63 Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ten63 Therapeutics

Location

E Tropicana Ave #2

Durham, North Carolina, United States

About

Ten63 Therapeutics is focused on improving human health by developing better, more durable therapeutics against cancer and some of the world’s most lethal diseases. We are leveraging our proprietary in silico platform BEYOND to generate novel therapeutics to hit previously undruggable targets while bringing the paradigm of durable response into early drug design through our unique ability to predict and overcome drug resistance. We are hiring. At Ten63, we want a better world with healthier people! We value passion, teamwork, out of the box thinking and determination to solve even what seems impossible. We embrace diversity and are committed towards inclusion. If you think you have what it takes to be a part of out team, please apply.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ten63 Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMarcel F., Executive Officer, Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Ten63 Therapeutics's next move

See what Strategic adds

Ten63 Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.